285 results on '"Hoxha, Ariela"'
Search Results
2. Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study
3. Short and long-term outcomes of children with autoimmune congenital heart block treated with a combined maternal-neonatal therapy. A comparison study
4. COVID-19 vaccine and the risk of flares in inflammatory arthritis: a systematic literature review and meta-analysis.
5. Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis.
6. Editorial: Women in obstetric and pediatric pharmacology: 2023
7. Obstetric Antiphospholipid Syndrome
8. The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus
9. The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies
10. Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospective Italian P-RHEUM.it study
11. Myocardial Involvement in Catastrophic Antiphospholipid Syndrome during Pregnancy or Puerperium: A Case of a Young Breastfeeding Woman and Literature Review.
12. Therapeutic apheresis during pregnancy: A single center experience
13. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers
14. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases
15. Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospective Italian P-RHEUM. it study.
16. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
17. Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report
18. Devenir de la grossesse et de l’enfant après traitement par anti-TNF alpha : étude prospective multicentrique
19. The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort study
20. Corrigendum to “Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group” [Placenta. 136 (2023 Apr 3) 29–34]
21. Detection of lupus anticoagulant in the era of direct oral anticoagulants
22. Pertinence clinique de la détection précoce des anticorps anti-adalimumab dans la polyarthrite rhumatoïde, la spondylarthrite ankylosante et le rhumatisme psoriasique : étude multicentrique prospective
23. Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients
24. Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study
25. The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study
26. The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review.
27. Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech/Pfizer) Vaccine Successfully Treated with Mepolizumab: A Case Report and Review of the Literature
28. Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block
29. The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome
30. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome
31. A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay
32. Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review
33. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block
34. The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review
35. Erosive osteoarthritis, psoriatic arthritis and pseudogout; a casual association?
36. The prevalence of monosodium urate and calcium pyrophosphate crystals in synovial fluid from wrist and finger joints
37. Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
38. A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro/La-related congenital atrioventricular block. A case series and review of the literature
39. Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature
40. COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis
41. Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
42. Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study
43. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study
44. Corrigendum to: Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from EUROAPS registry
45. Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome
46. Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two‐year outcomes after the study closure
47. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome
48. Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block
49. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method
50. High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.